2023-09-012024-08-312024-08-31false13583515BIOINNO UK LIMITED2025-05-2846450falseiso4217:GBPxbrli:pure135835152023-09-01135835152024-08-31135835152023-09-012024-08-31135835152022-09-01135835152023-08-31135835152022-09-012023-08-3113583515bus:SmallEntities2023-09-012024-08-3113583515bus:AuditExempt-NoAccountantsReport2023-09-012024-08-3113583515bus:FullAccounts2023-09-012024-08-3113583515bus:PrivateLimitedCompanyLtd2023-09-012024-08-3113583515core:WithinOneYear2024-08-3113583515core:AfterOneYear2024-08-3113583515core:WithinOneYear2023-08-3113583515core:AfterOneYear2023-08-3113583515core:ShareCapital2024-08-3113583515core:SharePremium2024-08-3113583515core:RevaluationReserve2024-08-3113583515core:OtherReservesSubtotal2024-08-3113583515core:RetainedEarningsAccumulatedLosses2024-08-3113583515core:ShareCapital2023-08-3113583515core:SharePremium2023-08-3113583515core:RevaluationReserve2023-08-3113583515core:OtherReservesSubtotal2023-08-3113583515core:RetainedEarningsAccumulatedLosses2023-08-3113583515core:LandBuildings2024-08-3113583515core:PlantMachinery2024-08-3113583515core:Vehicles2024-08-3113583515core:FurnitureFittings2024-08-3113583515core:OfficeEquipment2024-08-3113583515core:NetGoodwill2024-08-3113583515core:IntangibleAssetsOtherThanGoodwill2024-08-3113583515core:ListedExchangeTraded2024-08-3113583515core:UnlistedNon-exchangeTraded2024-08-3113583515core:LandBuildings2023-08-3113583515core:PlantMachinery2023-08-3113583515core:Vehicles2023-08-3113583515core:FurnitureFittings2023-08-3113583515core:OfficeEquipment2023-08-3113583515core:NetGoodwill2023-08-3113583515core:IntangibleAssetsOtherThanGoodwill2023-08-3113583515core:ListedExchangeTraded2023-08-3113583515core:UnlistedNon-exchangeTraded2023-08-3113583515core:LandBuildings2023-09-012024-08-3113583515core:PlantMachinery2023-09-012024-08-3113583515core:Vehicles2023-09-012024-08-3113583515core:FurnitureFittings2023-09-012024-08-3113583515core:OfficeEquipment2023-09-012024-08-3113583515core:NetGoodwill2023-09-012024-08-3113583515core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3113583515core:ListedExchangeTraded2023-09-012024-08-3113583515core:UnlistedNon-exchangeTraded2023-09-012024-08-3113583515core:MoreThanFiveYears2023-09-012024-08-3113583515core:Non-currentFinancialInstruments2024-08-3113583515core:Non-currentFinancialInstruments2023-08-3113583515dpl:CostSales2023-09-012024-08-3113583515dpl:DistributionCosts2023-09-012024-08-3113583515core:LandBuildings2023-09-012024-08-3113583515core:PlantMachinery2023-09-012024-08-3113583515core:Vehicles2023-09-012024-08-3113583515core:FurnitureFittings2023-09-012024-08-3113583515core:OfficeEquipment2023-09-012024-08-3113583515dpl:AdministrativeExpenses2023-09-012024-08-3113583515core:NetGoodwill2023-09-012024-08-3113583515core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3113583515dpl:GroupUndertakings2023-09-012024-08-3113583515dpl:ParticipatingInterests2023-09-012024-08-3113583515dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-012024-08-3113583515core:ListedExchangeTraded2023-09-012024-08-3113583515dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-012024-08-3113583515core:UnlistedNon-exchangeTraded2023-09-012024-08-3113583515dpl:CostSales2022-09-012023-08-3113583515dpl:DistributionCosts2022-09-012023-08-3113583515core:LandBuildings2022-09-012023-08-3113583515core:PlantMachinery2022-09-012023-08-3113583515core:Vehicles2022-09-012023-08-3113583515core:FurnitureFittings2022-09-012023-08-3113583515core:OfficeEquipment2022-09-012023-08-3113583515dpl:AdministrativeExpenses2022-09-012023-08-3113583515core:NetGoodwill2022-09-012023-08-3113583515core:IntangibleAssetsOtherThanGoodwill2022-09-012023-08-3113583515dpl:GroupUndertakings2022-09-012023-08-3113583515dpl:ParticipatingInterests2022-09-012023-08-3113583515dpl:GroupUndertakingscore:ListedExchangeTraded2022-09-012023-08-3113583515core:ListedExchangeTraded2022-09-012023-08-3113583515dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-09-012023-08-3113583515core:UnlistedNon-exchangeTraded2022-09-012023-08-3113583515core:NetGoodwill2024-08-3113583515core:IntangibleAssetsOtherThanGoodwill2024-08-3113583515core:LandBuildings2024-08-3113583515core:PlantMachinery2024-08-3113583515core:Vehicles2024-08-3113583515core:FurnitureFittings2024-08-3113583515core:OfficeEquipment2024-08-3113583515core:AfterOneYear2024-08-3113583515core:WithinOneYear2024-08-3113583515core:ListedExchangeTraded2024-08-3113583515core:UnlistedNon-exchangeTraded2024-08-3113583515core:ShareCapital2024-08-3113583515core:SharePremium2024-08-3113583515core:RevaluationReserve2024-08-3113583515core:OtherReservesSubtotal2024-08-3113583515core:RetainedEarningsAccumulatedLosses2024-08-3113583515core:NetGoodwill2023-08-3113583515core:IntangibleAssetsOtherThanGoodwill2023-08-3113583515core:LandBuildings2023-08-3113583515core:PlantMachinery2023-08-3113583515core:Vehicles2023-08-3113583515core:FurnitureFittings2023-08-3113583515core:OfficeEquipment2023-08-3113583515core:AfterOneYear2023-08-3113583515core:WithinOneYear2023-08-3113583515core:ListedExchangeTraded2023-08-3113583515core:UnlistedNon-exchangeTraded2023-08-3113583515core:ShareCapital2023-08-3113583515core:SharePremium2023-08-3113583515core:RevaluationReserve2023-08-3113583515core:OtherReservesSubtotal2023-08-3113583515core:RetainedEarningsAccumulatedLosses2023-08-3113583515core:NetGoodwill2022-09-0113583515core:IntangibleAssetsOtherThanGoodwill2022-09-0113583515core:LandBuildings2022-09-0113583515core:PlantMachinery2022-09-0113583515core:Vehicles2022-09-0113583515core:FurnitureFittings2022-09-0113583515core:OfficeEquipment2022-09-0113583515core:AfterOneYear2022-09-0113583515core:WithinOneYear2022-09-0113583515core:ListedExchangeTraded2022-09-0113583515core:UnlistedNon-exchangeTraded2022-09-0113583515core:ShareCapital2022-09-0113583515core:SharePremium2022-09-0113583515core:RevaluationReserve2022-09-0113583515core:OtherReservesSubtotal2022-09-0113583515core:RetainedEarningsAccumulatedLosses2022-09-0113583515core:AfterOneYear2023-09-012024-08-3113583515core:WithinOneYear2023-09-012024-08-3113583515core:Non-currentFinancialInstrumentscore:CostValuation2023-09-012024-08-3113583515core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-09-012024-08-3113583515core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-09-012024-08-3113583515core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-09-012024-08-3113583515core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-09-012024-08-3113583515core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-09-012024-08-3113583515core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3113583515core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3113583515core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-09-012024-08-3113583515core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3113583515core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3113583515core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3113583515core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3113583515core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3113583515core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3113583515core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3113583515core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3113583515core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3113583515core:Non-currentFinancialInstrumentscore:CostValuation2023-08-3113583515core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-3113583515core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-3113583515core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-3113583515core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-3113583515core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-3113583515core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-3113583515core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-3113583515core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-3113583515bus:Director12023-09-012024-08-31

BIOINNO UK LIMITED

Registered Number
13583515
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2024

BIOINNO UK LIMITED
Company Information
for the year from 1 September 2023 to 31 August 2024

Director

JIANG, Junjie

Registered Address

52 Grosvenor Gardens
London
SW1W 0AU

Registered Number

13583515 (England and Wales)
BIOINNO UK LIMITED
Statement of Financial Position
31 August 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Tangible assets33,1874,249
3,1874,249
Current assets
Debtors44,3906,485
Cash at bank and on hand109,50716,451
153,89722,936
Creditors amounts falling due within one year4(129,220)(44,638)
Net current assets (liabilities)24,677(21,702)
Total assets less current liabilities27,864(17,453)
Provisions for liabilities5(1,062)-
Net assets26,802(17,453)
Capital and reserves
Called up share capital1,0001,000
Profit and loss account25,802(18,453)
Shareholders' funds26,802(17,453)
The financial statements were approved and authorised for issue by the Director on 28 May 2025, and are signed on its behalf by:
JIANG, Junjie
Director
Registered Company No. 13583515
BIOINNO UK LIMITED
Notes to the Financial Statements
for the year ended 31 August 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A, as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible assets are initially measured at cost, and are subsequently measured at cost less any accumulated depreciation and accumulated impairment losses or at a revalued amount. Any tangible assets carried at a revalued amount are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation is recognised in other comprehensive income and accumulated in capital and reserves. However, the increase is recognised in profit or loss to the extent that it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves. If a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess is recognised in profit or loss.

Reducing balance (%)
Office Equipment3,187
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20242023
Average number of employees during the year22
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 September 235,3115,311
At 31 August 245,3115,311
Depreciation and impairment
At 01 September 231,0621,062
Charge for year1,0621,062
At 31 August 242,1242,124
Net book value
At 31 August 243,1873,187
At 31 August 234,2494,249
4.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables97,20234,365
Taxation and social security4,961-
Other creditors27,05710,273
Total129,22044,638
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
5.Provisions for liabilities

2024

2023

££
Net deferred tax liability (asset)1,062-
Total1,062-